AnaptysBio incurred a GAAP loss of $29.81 million in 6 months of 2020, down 35.3% from $46.04 million the previous year. Revenue increased by 3 times to $15 mln compared to $5 mln a year earlier.
AnaptysBio incurred a GAAP loss of $29.81 million in 6 months of 2020, down 35.3% from $46.04 million the previous year. Revenue increased by 3 times to $15 mln compared to $5 mln a year earlier. 
ir.anaptysbio.com
English (US) 